Cent
Category: AI in Healthcare
An AI-powered preventive healthcare intelligence platform focused on early detection of cancer, cardiac, neurological, and metabolic (CCNM) diseases before symptoms appear, using multi-modal imaging, biomarkers, and AI synthesis. Cent was founded in 2023. The company is led by Shashank ND. Based in Bengaluru, India. Team size: N/A. Total funding raised: $5.0M. Latest round: Seed ($5.0M, Mar 2026). Key investors include ["OneFlow Holdings","South Park Commons"].
- Founded
- 2023
- Headquarters
- Bengaluru, India
- Team size
- N/A
- Total funding
- $5.0M
Value proposition
Detects life-threatening diseases at 'Stage 0' or 'Stage 1' when survival rates are exponentially higher, through comprehensive multi-modal screening (full-body MRI, CT, DEXA, 120+ biomarkers, genetics) with AI-powered synthesis, identifying 300+ conditions responsible for 80%+ of premature deaths with 26% clinically meaningful detection rate in initial scans.
Products and solutions
["CCNM™ Protocol (Cardiac, Cancer, Neurological, Metabolic Screening)","Full-Body MRI Scan","CT Calcium Scoring for Heart Blockage Detection","DEXA Body Composition & Bone Density Analysis","Blood X: 120+ Biomarker Analysis","Tru10™ Organ-Wise Health Scoring System","AI-Powered Health Intelligence Dashboard","Genetic Risk Mapping Module (Add-On)","Doctor-Reviewed Reports with Specialist Consultation","At-Home Blood & Urine Collection Service"]
Unique value
Pioneers 'zero-symptom' diagnostics focused exclusively on pre-symptomatic disease detection at Stage 0/Stage 1, combining full-body MRI, low-dose CT, DEXA, ECG, 120+ biomarkers, and optional genetic testing into a single standardized workflow. Proprietary CCNM™ protocol targets 300+ conditions responsible for 80%+ of premature deaths. Achieved 26% clinically meaningful detection rate in 1,500+ initial scans, with 4% identifying critical conditions in completely asymptomatic individuals.
Target customer
Direct-to-consumer (D2C) asymptomatic individuals aged 30+ seeking proactive health screening; health-conscious adults focused on preventive care and longevity; high-net-worth individuals and executives prioritizing comprehensive health monitoring
Industries served
["Preventive Healthcare","Medical Diagnostics","Healthcare AI","Health Screening & Wellness","Medical Imaging","Diagnostic Imaging Centers"]
Technology advantage
Integrates advanced multi-modal diagnostics (whole-body MRI, cardiac CT, DEXA, comprehensive biomarkers) with AI-powered synthesis and medical specialist validation into a unified D2C platform. Unlike traditional health checkups that use tiered packages and limited imaging (typically ultrasound only), Cent offers comprehensive imaging with no tiers—one complete scan at ₹27,500-₹40,000 early access price. The Tru10™ scoring system provides organ-level risk assessments, enabling personalized health optimization. Single-purpose, standardized workflow designed specifically for CCNM condition detection ensures consistency and accuracy across all centers.
How they differentiate
Cent differentiates through its proprietary CCNM™ protocol (Cardiac, Cancer, Neurological, Metabolic) designed specifically for the Indian market, integrating full-body MRI, low-dose CT, DEXA, ECG, and 120+ biomarkers with AI-driven synthesis into a single standardized D2C workflow. Unlike global competitors focused on Western markets, Cent offers comprehensive multi-modal screening at ₹27,500-₹40,000 (early access pricing), significantly more affordable than Western counterparts ($2,000-2,500). The platform uniquely targets 300+ conditions responsible for 80%+ of premature deaths with a 26% clinically meaningful detection rate in asymptomatic individuals.
Main competitors
["Prenuvo","Function Health","Neko Health"]
Key partnerships
["OneFlow Holdings (Shashank ND's family office - Lead Investor)","South Park Commons (Investor - US-based VC firm)","Healthcare provider partnerships for specialized imaging centers (in development)","Expansion partnerships planned for Pune and Hyderabad markets","Clinical validation partnerships with radiologists and medical specialists"]
Notable customers
[]
Major milestones
["Founded in 2023 by Practo co-founder Shashank ND with experienced team from Lenskart and Ola Electric","Developed proprietary CCNM™ protocol for screening 300+ conditions","Conducted 1,500+ scans during initial operations with strong detection rates","Raised $5M seed funding from OneFlow Holdings and South Park Commons (Mar 2026)","Official launch announced Mar 6, 2026 following months of live operations","Planning to launch specialized centers in Bengaluru, Mumbai, and Delhi starting Mar-Apr 2026"]
Growth metrics
Conducted 1,500+ scans with 26% showing clinically meaningful findings and 4% identifying critical conditions in asymptomatic individuals; achieved $2M ARR with 50% month-on-month growth
Market positioning
Early-stage D2C preventive healthcare intelligence platform positioning as India's first dedicated 'zero-symptom' diagnostic service. Targets health-conscious individuals aged 30+, high-net-worth individuals, and executives seeking proactive health screening. Competes in the emerging preventive healthcare segment in India, distinguishing itself from traditional health checkups through comprehensive imaging and AI-powered early disease detection.
Geographic focus
India - Launching specialized early detection centers in Bengaluru, Mumbai, and Delhi (March-April 2026), with expansion plans for Pune and Hyderabad
Patents and IP
No registered patents publicly disclosed as of March 2026. Proprietary technologies include CCNM™ protocol and Tru10™ organ-wise scoring system protected as trade secrets and intellectual property.
About Shashank ND
Founder & CEO of Practo (2008-present), India's leading healthcare technology platform. Founded Practo as a college project and scaled it to serve 200M+ users across 15 countries. Expertise in healthcare technology, digital health platforms, and AI-driven healthcare solutions. Featured in Forbes 30 Under 30 Asia (2017). Economic Times Startup of the Year recognition. Now Founder & Chair of Cent, focused on AI-powered preventive health intelligence.
Official website: https://www.centai.in/